➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Harvard Business School
Johnson and Johnson
McKinsey
Medtronic

Last Updated: September 29, 2020

DrugPatentWatch Database Preview

Litigation Details for In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES. (D. Kan. 2017)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES. (D. Kan. 2017)

Docket   Start Trial Date Filed 2017-08-04
Court District Court, D. Kansas Date Terminated
Cause 28:1407 Multi-District Litigation Assigned To Daniel Dale Crabtree
Jury Demand Both Referred To Teresa James
Parties ADAM KLEIN; AETNA INC.; ALENE MCDANIEL; ALL DEFENDANTS (FOR LEAD/LIAISON COUNSEL ONLY); ALL PLAINTIFFS (FOR LEAD/LIAISON COUNSEL ONLY); AMBER RAINEY; AMERIGROUP CORPORATION; AMIE VIALET DE MONTBEL; ANASTASIA JOHNSTON; ANGIE NORDSTRUM; ANNETTE SUTORIK; ANTHEM INSURANCE COMPANIES, INC.; ANTHEM, INC.; APRIL SUMNER; ARISSA PASCHALIDIS; BLUE CROSS BLUE SHIELD MASSACHUSETTS; BLUE HORIZON CROSS BLUE SHIELD OF NEW JERSEY; CAREFIRST, INC.; CARLY BOWERSOCK; CASSANDRA BREDEK; CASSANDRA COBB; CHANGE HEALTHCARE, INC.; CHRIS RIPPY; CHRISTINA JAMES; CHRISTINA KOLLMEYER; CONNIE STAFFORD; CONSUMER CLASS CASES PLAINTIFFS; COVENTRY HEALTH CARE; CURT PALMER; CVS HEALTH CORPORATION; DAVID H. SMITH; DENYA ANDERSON; DONNA ANNE DVORAK; DONNA WEMPLE; EILEEN MONTET; ELAN KLEIN; ELIZABETH HUELSMAN; ELIZABETH WILLIAMSON; EPIPEN (EPINEPHRINE INJECTION, USP) MARKETING, SALES PRACTICES AND ANTITRUST LITIGATION; ERIN KORTE-LAMPARTER; EXPRESS SCRIPTS HOLDING COMPANY; EXPRESS SCRIPTS, INC.; FRANCIS MEYERS; HEATHER BRESCH; HEATHER DESTEFANO; HEATHER RULAND; HONORABLE MARGARET R. HINKLE (RET.); HUMANA PHARMACY SOLUTIONS, INC.; HUMANA, INC.; JAE JONES; JAMIE HERR; JENNIFER WALTON; JOHN DODGE; JOY SHEPARD; JUDICIAL PANEL ON MULTIDISTRICT LITIGATION; KAISER FOUNDATION HEALTH PLAN, INC.; KAISER FOUNDATION HOSPITALS; KALEO, INC.; KENNETH EVANS; KENNETH STEINHAUSER; KIMBERLY CORCORAN; KIMBERLY DOLLANDER; KING PHARMACEUTICALS, INC.; KING PHARMACEUTICALS, LLC; KPH HEALTHCARE SERVICES, INC.; LANDON IPSON; LAURA CHAPIN; LAUREN COALE; LEAH WEAVER; LEE SELTZER; LESLEY HUSTON; LINDA WAGNER; LINDSEY RIZZO; LISA VOGEL; LOCAL 282 WELFARE TRUST FUND; LORI COLLINS; LORRAINE WIGHT; MARIA GIURLAND; MARK KOVARIK; MEDIMPACT HEALTHCARE SYSTEMS, INC.; MEREDITH KRIMMEL; MERIDIAN MEDICAL TECHNOLOGIES, INC.; MICHAEL GILL; MIRIAM CLARKE; MYLAN N.V.; MYLAN PHARMACEUTICALS, INC.; MYLAN SPECIALTY, LP; MYLAN, INC.; NIKITIA MARSHALL; OPTUMRX, INC.; PFIZER, INC.; PLAINTIFFS' STEERING COMMITTEE; PRIME THERAPEUTICS, LLC; RACHEL FERNANDEZ; RAYMOND C. BUCHTA, III; ROBERT MONTOYA; ROSETTA SERRANO; SANOFI-AVENTIS US, LLC; SEGAL GROUP, INC.; SHANNON CLEMENTS; SONYA NORTH; STACEE SVITES; SUZANNE HARWOOD; TEIA AMELL; TEVA PHARMACEUTICAL USA, INC.; THOMAS HADLEY; TODD BEAULIEU; TRACI BRANNON; UNITEDHEALTH GROUP, INC.; VALERIE MOORE; VISHAL AGGARWAL; WILLIAM DELPRINCIPE
Patents 6,996,927; 7,449,012; 7,794,432; 8,961,968; 8,961,973; 8,980,931; 8,992,352; 9,603,943
Attorneys Ada Wang; Adam K. Levin; Adam Scott Tolin; Alison Elizabeth Chase; Amanda Klevorn; Angela (Angel) D. Mitchell; Archie Irwin Grubb , II; Arnold B. Calmann; Arthur L. Shingler , III; Arthur R. Miller; Ben Barnow; Benjamin Frederick Holt; Bradley Beall; Bradley Joseph Schlozman; Brendan Woodard; Brian C. Fries; Brian D. Penny; Brian Murphy; Brian O. O'Mara; Brian R. Richichi; Brigid Bone; Camille S. Bass; Carolyn Anne DeLone; Chad E. Blomberg; Charles A. Loughlin; Charles Jacob Gower; Charles T. Schimmel; Chenyuan Fu; Christopher D. Edelman; Christopher Holding; Christopher J. Cormier; Craig L. Briskin; Cristina R. Delise; Damien J. Marshall; Daniel C. Hedlund; Daniel E. Gustafson; Daniel Thomas Graham; David A. Perez; David E. Delorenzi; David F. Oliver; David M. Foster; Dennis Lienhardt , Jr.; Derek William Loeser; Devan Calleen Rittler-Patton; Devon Paul Allard; Diane P. Sullivan; Dimitrios Drivas; Donald A. Ecklund; Duane L. Loft; E. Powell Miller; Edward Thrasher; Elizabeth C. Pritzker; Emily Hughes; Eric Andrew Rivas; Eric D. Barton; Eric Fierro; Eric Shaun Hochstadt; Erich Paul Schork; Erin Marie James; Eugene Mikolajczyk; Felicia Craick; Gregory M. Bentz; Gretchen Freeman Cappio; Ian S. Millican; Isaac L. Diel; Ivan Navedo; J. Nick Badgerow; Jacob Benjamin Ebin; James Bringhurst Eubank; James E. Cecchi; James Moloney; Jason Scott Goldstein; Jeffrey N. Luthi; Jeffrey S. Soos; Jennifer B. Wieland; Jennifer Fountain Connolly; Jennifer Kan; Jennifer Varon; Jessica Arden Ettinger; Jiamie Chen; John A. Stratford; John Bagnall Webb; John Bredehoft; John Goerlich; John Robert Robertson; Jon Myer Talotta; Jonathan K. Levine; Joseph Adamson; Joseph Alm; Joseph C. Bourne; Joseph G. Sauder; Joseph M. Rebein; Justin Bernick; Kasie M. Braswell; Katherine Booth Wellington; Kathryn M. Ali; Kathryn Swisher; Kathryn Zecca; Keith O'Doherty; Kersten L. Holzhueter; Kimberly Rancour; Korey Nelson; Lauren Jacobson; Lea Bays; Lee Turner Friedman; Lisa Marie Madalone; Luna Ngan Barrington; Lydia Wright; Lynn Lincoln Sarko; Mahde Youssef Abdallah; Maissa Chouraki; Mark Palley; Mary Mifflin Drake; Matthew S. Tripolitsiotis; Maxwell Goins; Melissa Rutman; Michael David Gendall; Michael J. Prame; Michael W. Meredith; Mitchell E. Zamoff; Mitchell L. Herren; Nathaniel David White; Patrick Thomas Egan; Paul J. Geller; Peter D. St. Phillip , Jr.; Philip A. Sechler; Raj Gandesha; Ralph C. Mayrell; Randi Singer; Reagan E. Bradford; Rex A. Sharp; Robert Ashby Pate; Robert E. Boston; Robert Milne; Robert William Taylor; Rosemary Medellin Rivas; Roy T. Englert , Jr.; Ryan C. Hudson; Ryan McDevitt; Samuel Kadosh; Sandra J. Durkin; Sarah Humble; Sarah L. Segal; Scott B. Goodger; Scott Simmer; Sean Murray; Sharon S. Almonrode; Sheryn George; Silvia M. Medina; Spencer Cox; Stacy A. Burrows; Stephen J. Fearon , Jr.; Steve W. Berman; Steven N. Williams; Steven Rivera; Stuart A. Davidson; Sue Lin; Susan E. Foster; Tanya Korkhov; Taylor Foye; Thomas J. Hershewe; Thomas L. Boeder; Thomas P. Cartmell; Timothy Gordon Blood; Timothy Robert Herman; Tyler W. Hudson; Ursula A. Taylor; W. Daniel Miles , III; W. Greg Wright; W. Mark Lanier; Warren T. Burns; William D. Beil; William L. Kalas; Yehudah L. Buchweitz; Yuri Fuchs
Firms Angela (Angel) D. Mitchell; Archie Irwin Grubb , II; Barnow and Associates PC; Baron & Budd, PC; Beasley Allen Crow Methvin Portis & Miles; Berkowitz Oliver LLP KCMO; Blood Hurst & O'Reardon, LLP; Blood Hurst and O'Reardon LLP; Boies, Schiller & Flexner LLP (Armonk); Boies, Schiller & Flexner LLP (DC); Boies, Schiller & Flexner, LLP - NY; Braswell Murphy, LLC; Burns Charest New Orleans; Burns Charest, LLP Dallas; Burns Charest, LLP Greenwood Village; CAD Law, LC; Carella, Byrne, Cecchi, Olstein, Brody & Agnello, PC; Cerner Corporation MO; Clerk of the MDL Panel; Cotchett Pitre and McCarthy; Daniel Thomas Graham; DLA Piper LLP (US); Dollar, Burns & Becker, LC; German May PC; Goldman, Scarlato & Penny, Pc; Goodwin Procter, LLP MA; Groom Law Group, Chartered; Hagens Berman Sobol Shapiro LLP Seattle; Hinkle Law Firm LLC East Wichita Office; Hogan Lovells US LLP; Hogan Lovells US LLP MN; Hogan Lovells US, LLP DC; Hogan Lovells US, LLP DC555; Hogan Lovells, US LLP-DC; Joseph Saveri Law Firm; Joseph Saveri Law Firm, Inc.; Kaufman & Canoles; Keller Rohrback, LLC Seattle; Keller Rohrback, LLP New York; Keller Rohrback, LLP-Phoenix; Keller Rohrback, LLP-Santa Barbara; Lathrop Gage, LLP Kansas City; Lathrop GPM, LLP Kansas City; Law Offices of George A. Barton, PC; Levi & Korsinsky, LLP; Lightfoot Franklin White; Lowey Dannenberg, Pc; Marion's Inn LLP; Mayer Brown LLP; McCune Wright Arevalo, LLP; Mehri & Skalet PLLC; Miller Law Firm Pc; Pearson Simon & Warshaw LLP; Perkins Coie LLP Seattle; Pritzker Levine LLP; Reed Smith; Rex a Sharp PA; Robbins Geller Rudman & Dowd LLP (San Diego); Robbins Geller Rudman & Dowd, LLP - Boca Raton; Robbins, Russell, Englert, Orseck, Untereiner & Sauber LLP; Robins Geller Rudman & Dowd LLP - FL; Robins Kaplan LLP; Sharp Barton, LLP; Sharp Barton, LLP Metcalf; Sharp Law; Sharp Law, LLP College Blvd.; Sharp McQueen PA OP; Shook, Hardy & Bacon LLP - KC/Grand; Spencer Fane LLP KC; Squitieri and Fearon LLP; Steven Rivera; Strategic Health Law; Susan E. Foster; The Lanier Law Firm; The Lanier Law Firm PC; The Lanier Law Firm, PC; The Miller Law Firm; Timothy Robert Herman; U.S. Department of Justice Civil Division; Wagstaff & Cartmell LLP; Waller, Lansden, Dortch & Davis, L.L.C.; Weil, Gotshal & Manges LLP - Dallas; Weil, Gotshal & Manges LLP (CA); Weil, Gotshal & Manges, LLP - New York; Weil, Gotshal & Manges, LLP - NJ; Wexler Wallace LLP; White & Case LLP (NY)
Link to Docket External link to docket
Small Molecule Drugs cited in In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .
Biologic Drugs cited in In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES.

The biologic drugs covered by the patents cited in this case are   Start Trial ,   Start Trial ,   Start Trial , and   Start Trial .

Details for In Re: Epipen (Epinephrine Injection, USP) Marketing, Sales Practices and Antitrust Litigation COUNSEL: DO NOT ADD PARTIES. (D. Kan. 2017)

Date Filed Document No. Description Snippet Link To Document
2020-02-27 2017 Memorandum & Order - Unsealed Copy evidence that the ’432 Patent is unenforceable due to patent misuse?” Doc. 1837-8 at 3 (Pls.’ Statement… likely outcome of the underlying patent litigation.” Doc. 1848 at 8 n.10. Plaintiffs respond that Prof…litigation (a lawsuit related to the Teva patent litigation). Doc. 1837-8 at 3 (Pls.’ Statement of Contested…428 U.S. at 121); see also Celgene Corp. v. Peter, 931 F.3d 1342, 1356 (Fed. Cir. 2019) (recognizing that…the fact that it was not raised below.” Celegene, 931 F.3d at 1356 (citations omitted). External link to document
2020-02-27 2018 Memorandum & Order - Unsealed Copy pending resolution of the patent litigation King had filed. Doc. 1500 at 33. Six months later, the parties…Wellness Ctr., LLC v. Medtox Sci., Inc., 821 F.3d 992, 996 (8th Cir. 2016) (discussing criticism of the Third…Wellness Ctr., LLC v. Medtox Sci., Inc., 821 F.3d 992, 996 (8th Cir. 2016); and then citing Rikos v. Procter…provided by law”); Freeman v. Sorchych, 245 P.3d 927, 936 (Ariz. Ct. App. 2011) (listing one of the elements… Patent Infringement Lawsuits The Pfizer defendants own the patents protecting the External link to document
2020-04-22 2059 Order on Motion for Leave to File Nuvigil patent infringement Case 2:17-md-02785-DDC-TJJ Document 2059 Filed 04/22/20 Page 2 of 8 …compliance by filing a motion to compel (ECF No. 992). On October 5, 2018, the Court granted Class Plaintiffs…). 6 Pfeiffer v. Eagle Mfg. Co., 137 F.R.D. 352, 355 (D. Kan. 1991). 7 Deghand, 904 F. Supp. … allegation that the April 2012 settlement of patent infringement claims involving EpiPen… allegations that the April 2012 settlement of patent infringement claims involving EpiPen and Nuvigil External link to document
2017-10-17 60 Amended Complaint 8, 2009) alleging infringement of U.S. Patent No. 7,449,012. King filed a First Amended Complaint on…equivalents, and any patents that purportedly protect each drug. 113. Drug patents typically last…ordinary patent term of twenty years, often compensate for unfairness in the ordinary patent process …not infringe any patents claiming to cover the reference product because: (1) no patents are listed in …drug until all applicable patents have expired; or (4) all applicable patents are invalid or will not External link to document
2018-08-20 896 Order on Motion to Dismiss Meridian—sued Teva for infringing U.S. Patent No. 7,449,012 (“the Teva Litigation”). In November 2010…Defendants did so by adding several more patents to the already-patented EpiPen to prevent the launch of competing…2009 that Mylan was adding another patent to the already-patented EpiPen device that “will also put in… ’432 patent. Later, King and Meridian dropped their claims based on infringing the ’012 patent, leaving…that Intelliject’s EAI infringed the ’432 patent—a patent that Meridian secured more than a year after External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
AstraZeneca
Mallinckrodt
Medtronic
Merck
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.